1. 2007 Medical Education Conference Conférence de 2007 sur l’éducation médicale Welcome AFMC – CAME – CFPC – MCC – RCPSC AFMC – ACÉM – CMFC – CMC – CRMCC Bienvenue

2. Using Electronic Health Records For education and research Robyn Tamblyn, McGill University

3. Outline Key Components of Electronic Health Records Key Components of Electronic Health Records Uses in Education Uses in Education Uses in Research Uses in Research

4. Key Components of EHR

5. Health Problem List Medication List Retrieval of lab, drug, dx test + report information from feeder systems

6. Drug and Visit Profile Information from Regional/ Provincial Repositories Costs of Medications Dates of Hospitalizations & ER Visits List of Drugs Dispensed over Past 6 Months.

7. Structured order entry

8. Clinical Notes

9. Uses in Education

10. Reminders Educate About Preventive Care and Provide Practice Reminders

12. E-Rx Pad Educate + Reduce Potential Errors by Providing Menus for Dose Selection & Treatment Indication cou

13. Educate about Drug Interactions & Reduce Errors in Drug Selection by Providing Alerts for Prescribing Problems

14. Evidence-Based Asthma Decision Support Customized for Individual Patient Profiles CIHR supported RCT-2004-2008

15. Uses in Research

16. Practice Profiles

17. Vulnerable Patients Risk Factor Management CHFDiabetesHypertension COPDAsthma My Practice Profile

18. My Asthma Patients Vulnerable Patients Risk Factor Management CHFDiabetesHypertension My Practice Profile COPDAsthma Asthma Quality Indicators Proportion of my asthma patients with poor control Compliance with Rx All asthma patients should have an action plan All asthma patients with poor control should have inhaled corticosteroids Disease Control Show me my current asthma treatment outcomes Compare my asthma treatment outcomes to those of my peers

19. My Asthma Patients Asthma Quality Indicators Proportion of my asthma patients with poor control Compliance with Rx All asthma patients should have an action plan All asthma patients with poor control should have inhaled corticosteroids Disease Control Compare my asthma treatment outcomes for the past 2 years Compare my asthma treatment outcomes to those of my peers Vulnerable Patients Risk Factor Management CHFDiabetesHypertension My Practice Profile COPDAsthma

20. My Asthma Patients Compare my asthma treatment outcomes for the past 2 years Compare my asthma treatment outcomes to those of my peers Asthma Quality Indicators Proportion of my asthma patients with poor control Compliance with Rx All asthma patients should have an action plan All asthma patients with poor control should have inhaled corticosteroids (guidelines) Disease Control Vulnerable Patients Risk Factor Management CHFDiabetesHypertension My Practice Profile COPDAsthma

21. My Asthma Patients Vulnerable Patients Risk Factor Management CHFDiabetesHypertension My Practice Profile COPDAsthma Asthma Quality Indicators Proportion of my asthma patients with poor control Compliance with Rx All asthma patients should have an action plan All asthma patients with poor control should have inhaled corticosteroids Disease Control Show me my current asthma treatment outcomes Compare my asthma treatment outcomes for the past 2 years

22. My Hypertension Patients My Practice Profile Asthma Vulnerable Patients Risk Factor Management CHFDiabetesCOPDHypertension Compare my hypertension treatment outcomes for the past 2 years Compare my hypertension treatment outcomes to those of my peers Hypertension Quality Indicators Hospitalizations for hypertension complications Compliance with Rx All hypertension patients should have their blood pressure monitored regularly All patients with complicated hypertension should be prescribed an ACE Inhibitor (unless contraindicated) Disease Control

23. The voyage begins… Thank you. robyn.tamblyn@mcgill.ca